This Specialized MDMA Producer Will Provide Psychedelics Exclusively For Canadian Massive Research Organization

A new deal has been signed between PharmAla Biotech Holdings Inc. (CSE: MDMA) and InterVivo Solutions for GMP MDMA and engineering MDMA supply towards research on its impact on neuropsychiatric and neurological diseases.

The agreement entails that PharmAla will provide both its clinical-grade and recently registered LaNeo MDMA, as well as engineering MDMA for further advancing expert pre-clinical in vivo (animal) research. InterVivo and its client companies will have exclusive access to the compounds at reduced prices and will have the possibility to use the MDMA once reaching the clinical (human) research stage.

InterVivo Solutions (IVS) provides research services using …

Full story available on Benzinga.com

More This Specialized MDMA Producer Will Provide Psychedelics Exclusively For Canadian Massive Research Organization